Nplate (Romiplostim Subcutaneous) - Current Clinical Trials

Nplate Related Clinical Trials

AMG 531 in Patients With Advanced Malignancy Receiving Treatment With Carboplatin [Recruiting]

Romiplostim in Increasing Low Platelet Counts in Patients With Multiple Myeloma Receiving Chemotherapy [Recruiting]

Romiplostim in Treating Hepatitis C-Infected Patients With Thrombocytopenia [Recruiting]

A Prospective, Study Evaluating Changes in Bone Marrow Morphology in Adult Subjects Receiving Romiplostim for the Treatment of Thrombocytopenia Associated With Immune (Idiopathic) Thrombocytopenia Purpura (ITP) [Recruiting]

Romiplostim Treatment of Thrombocytopenia in Subjects With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS) [Recruiting]

Interventional Study in Adult Subjects With Immune Thrombocytopenia Purpura Receiving Romiplostim [Recruiting]

Evaluating the Safety of Long Term Dosing of Romiplostim (Formerly AMG 531) in Thrombocytopenic Subjects With Myelodysplastic Syndromes (MDS) [Recruiting]

A Study Evaluating the Safety and Efficacy of Long-term Dosing of Romiplostim in Thrombocytopenic Pediatric Subjects With Immune (Idiopathic) Thrombocytopenia Purpura [Recruiting]

Secondary Prophylaxis in Non-Hodgkin Lymphoma (NHL) and Chemotherapy-induced Thrombocytopenia [Recruiting]

An Open Label Study of Romiplostim in Adult Thrombocytopenic Subjects With ITP [Recruiting]

Safety and Efficacy Study of Romiplostim to Treat ITP in Pediatric Subjects [Recruiting]

Long-term Safety Study of Treatment With the Thrombopoietin Agonists Eltrombopag and Romiplostim in Patients With Immune Thrombocytopenia (ITP) [Recruiting]

Study of AMG 531 to Evaluate the Safety & Efficacy in Patients With Non-Hodgkin's Lymphoma [Recruiting]